Ovid Therapeutics OVID
NASDAQ OVID
$2.38 -0.05 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2016 - 2026)

Updated

Ovid Therapeutics' Depreciation & Amortization (CF) came in at $16,000 for Q2 2026, down 83.8% from $99,000 a year earlier and down 54.3% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Ovid Therapeutics reported Depreciation & Amortization (CF) of $84,000, down 85.2% year-over-year; for FY2025, it was $273,000, down 55.5% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $613,000 in FY2024 (+7.9%), $568,000 in FY2023 (+10.8%), $512,505 in FY2022 (+116.2%) and $237,079 in FY2021 (-22.7%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $16,000 (Q3 2025) to $184,980 (Q4 2022).
  • Year-over-year, Depreciation & Amortization (CF) has declined for five consecutive quarters, with an average decline of 42.3% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2022 (growth of 224.8%), and the weakest in Q3 2025 (a decline of 90.5%).
  • Business Quant data shows OVID's Depreciation & Amortization (CF) at $35,000 (Q1 2026), $17,000 (Q4 2025) and $16,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Ovid Therapeutics 448.96 Mn 80.98 Mn - 16,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16,000.00
Mar 31, 2026 35,000.00
Dec 31, 2025 17,000.00
Sep 30, 2025 16,000.00
Jun 30, 2025 99,000.00
Mar 31, 2025 141,000.00
Dec 31, 2024 160,000.00
Sep 30, 2024 169,000.00
Jun 30, 2024 148,000.00
Mar 31, 2024 136,000.00
Dec 31, 2023 140,000.00
Sep 30, 2023 146,000.00
Jun 30, 2023 137,000.00
Mar 31, 2023 145,000.00
Dec 31, 2022 184,980.00
Sep 30, 2022 155,420.00
Jun 30, 2022 98,298.00
Mar 31, 2022 73,807.00
Dec 31, 2021 56,951.00
Sep 30, 2021 52,178.00
API Access

Ovid Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OVID&period=max&api_key=YOUR_API_KEY